An in-vitro quantitative investigation on the synergistic effect of capsaicin and 5-fluorouracil encapsulated into lipid nanocapsules to treat breast cancer

Abstract Background Breast cancer conventional therapeutics are effective; however, they encounter some limitations including multidrug resistance, the presence of pharmacological barriers, and non-selectivity which hinder their optimal therapeutic efficacy. Aim Overcoming such drawbacks necessitates the development of efficient drug vehicles including lipid-based nanoparticles. This study aimed to quantitatively investigate in-vitro the synergistic therapeutic effect of the novel combination of capsaicin and 5-fluorouracil (5-FU) encapsulated in lipid nanocapsules (LNCs). Method To this end, thorough physicochemical and in-vitro assessments on the breast cancer cell line (MCF-7) were done. The drug-loaded LNCs were characterized using DLS, TEM imaging, stability study, and in-vitro release study. Furthermore, the biological activity of the prepared LNCs was assessed by implementing comparative cytotoxicity studies as well as apoptosis, and cell cycle flow cytometric analyses. Results The developed nanoformulations were monodisperse with average particle size (PS) of 31, 43.8, and 127.3 nm for empty LNCs, Cap-LNCs, and 5-FU-LNCs, respectively, and with a surface charge of −35.4, −21.7 and −31.4 mV, respectively, reflecting good physical stability. The TEM micrographs revealed the spherical morphology of the drugs-loaded LNCs with comparable PS to that obtained by DLS. on the other hand, all the biological assessments confirmed the superior antiproliferative effect of the combined drug-loaded LNCs over their free drug counterparts. Conclusion Intriguingly, the study findings highlighted the potential synergistic activity of the drugs (capsaicin and 5-FU) and the extensive enhancement of their biological activity through incorporation into LNCs. Such promising results will pave the way to further novel combined nanoformulation in preclinical and clinical studies on breast cancer patients. Graphical Abstract

[1]  K. Edwards,et al.  Structural Characterization Study of a Lipid Nanocapsule Formulation Intended for Drug Delivery Applications Using Small-Angle Scattering Techniques , 2022, Molecular pharmaceutics.

[2]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[3]  Zhijie Liang,et al.  Capsaicin Inhibits Proliferation and Induces Apoptosis in Breast Cancer by Down-Regulating FBI-1-Mediated NF-κB Pathway , 2021, Drug design, development and therapy.

[4]  S. Krishnan,et al.  Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer , 2020, Scientific Reports.

[5]  Xiaomei Zhang,et al.  Oral co-delivery nanoemulsion of 5-fluorouracil and curcumin for synergistic effects against liver cancer , 2020, Expert opinion on drug delivery.

[6]  Xiao-ling Fang,et al.  Advances in anti-breast cancer drugs and the application of nano-drug delivery systems in breast cancer therapy , 2020 .

[7]  Yafei Xu,et al.  Application of capsaicin as a potential new therapeutic drug in human cancers , 2020, Journal of clinical pharmacy and therapeutics.

[8]  J. Varshosaz,et al.  Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line , 2019, Iranian journal of pharmaceutical research : IJPR.

[9]  V. Préat,et al.  Combinational Drug-Loaded Lipid Nanocapsules for the Treatment of Cancer. , 2019, International journal of pharmaceutics.

[10]  S. Ezzat,et al.  Bioactive glycoalkaloides isolated from Solanum melongena fruit peels with potential anticancer properties against hepatocellular carcinoma cells , 2019, Scientific Reports.

[11]  A. M. Al-Abd,et al.  Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities , 2018, Scientific Reports.

[12]  H. Mirzadeh,et al.  Combinational drug delivery using nanocarriers for breast cancer treatments: A review. , 2018, Journal of biomedical materials research. Part A.

[13]  A. Abdel-Naim,et al.  Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells. , 2018, Toxicology letters.

[14]  A. M. Al-Abd,et al.  Anticancer Profiling for Coumarins and Related O-Naphthoquinones from Mansonia gagei against Solid Tumor Cells In Vitro , 2018, Molecules.

[15]  P. Rai,et al.  Cancer nanomedicine: a review of recent success in drug delivery , 2017, Clinical and Translational Medicine.

[16]  A. M. Al-Abd,et al.  Cytotoxicity of thymoquinone alone or in combination with cisplatin (CDDP) against oral squamous cell carcinoma in vitro , 2017, Scientific Reports.

[17]  Lin Lv,et al.  Capsaicin-loaded folic acid-conjugated lipid nanoparticles for enhanced therapeutic efficacy in ovarian cancers. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  A. M. Al-Abd,et al.  New xanthones and cytotoxic constituents from Garcinia mangostana fruit hulls against human hepatocellular, breast, and colorectal cancer cell lines. , 2017, Journal of ethnopharmacology.

[19]  Xuesi Chen,et al.  Co-delivery of chemotherapeutics and proteins for synergistic therapy. , 2016, Advanced drug delivery reviews.

[20]  S. Zhang,et al.  Capsaicin Enhances the Drug Sensitivity of Cholangiocarcinoma through the Inhibition of Chemotherapeutic-Induced Autophagy , 2015, PloS one.

[21]  M. Alpay,et al.  Capsaicin inhibits cell proliferation by cytochrome c release in gastric cancer cells , 2014, Tumor Biology.

[22]  M. R. Mozafari,et al.  Formulation and characterization of nanoliposomal 5-fluorouracil for cancer nanotherapy , 2014, Journal of liposome research.

[23]  K. Bley,et al.  A Comprehensive Review of the Carcinogenic and Anticarcinogenic Potential of Capsaicin , 2012, Toxicologic pathology.

[24]  Randall D. Reif,et al.  Detection of apoptosis: A review of conventional and novel techniques , 2010 .

[25]  Gema Moreno-Bueno,et al.  Transcriptional profiling of MCF7 breast cancer cells in response to 5‐Fluorouracil: Relationship with cell cycle changes and apoptosis, and identification of novel targets of p53 , 2006, International journal of cancer.

[26]  R. Esenaliev,et al.  Effect of 5-fluorouracil, Optison and ultrasound on MCF-7 cell viability. , 2006, Ultrasound in medicine & biology.

[27]  D. Bazile,et al.  Influence of Lipid Nanocapsules Composition on Their Aptness to Freeze-Drying , 2005, Pharmaceutical Research.

[28]  J. Benoit,et al.  A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers , 2002, Pharmaceutical Research.

[29]  D. Scudiero,et al.  New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.

[30]  I. Díaz-Laviada,et al.  The potential antitumor effects of capsaicin. , 2014, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.